9517 Fair Value & Analysis
Basic Materials · Market cap 507M SAR
Fair value as of: Jul 31, 2026
From 24 valuation models · updated today
Share price −5.4% over the past month.
What matters now
- Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (5.38 SAR to 11.89 SAR) leaves room in how you read the outcome.
Price vs Fair Value (12 months)
12‑month range 9.38 SAR – 13.41 SAR · fair‑value band 5.38 SAR – 11.89 SAR · the 9.92 SAR price screens above the 7.30 SAR fair value. As of Jul 31, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
9517 (9517) currently trades at 9.92 SAR, while our model-based Fair Value estimate is 7.30 SAR, implying the stock looks roughly 26.4% overvalued today. We read business quality at 62/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, 9517 generated revenue of 255M SAR at a net margin of 12.4%. Revenue grew 18.9% year over year. It earns a return on equity of 37.1%. The balance sheet holds a net cash position of 4.3M SAR. Fundamentals as of Jul 31, 2026
Our scenario range runs from 5.38 SAR (bear case) to 11.89 SAR (bull case); at 9.92 SAR, the current price sits within that range. The share trades about 26% below its 52-week high and 10% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -52% fair-value upside, at -26%, 9517 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 31, 2026. TTM = trailing twelve months.
Quality Score breakdown
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
9517 reported revenue of 243M SAR in FY2025 versus 170M SAR in FY2021, a compound +9.3%/yr. Reported net income was 28.3M SAR in FY2025, compounding +15.1%/yr from FY2021.
Is 9517 fairly valued? → Check now
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | €448.00 | €191.66 | -57% |
| BASF SE BASN | 1,034 MXN | 201.87 MXN | -80% |
| Saudi Basic Industries Corporation 2010 | 49.60 SAR | 18.13 SAR | -63% |
| Ningxia Baofeng Energy Group 600989 | ¥23.43 | ¥34.39 | +47% |
| Dow Inc D1OW34 | R$43.92 | R$86.14 | +96% |
| Zhejiang Juhua Co 600160 | ¥39.27 | ¥17.39 | -56% |
| Rongsheng Petrochemical Co 002493 | ¥11.15 | ¥3.01 | -73% |
| PT Barito Pacific Tbk, BRPT | 1,760 IDR | 1,596 IDR | -9% |
| LG Chem, Ltd 051910 | 323,000 KRW | 311,741 KRW | -3% |
| Formosa Chemicals & Fibre Corporation 1326 | 46.25 TWD | 22.15 TWD | -52% |
Compare 9517 with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is 9517 overvalued or undervalued?
What is the fair value of 9517?
What is the quality score of 9517?
What is the revenue of 9517?
What is the net profit margin of 9517?
Does 9517 pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track 9517 and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.